Page last updated: 2024-08-21

dibenz(b,f)(1,4)oxazepine and allyl isothiocyanate

dibenz(b,f)(1,4)oxazepine has been researched along with allyl isothiocyanate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baraldi, PG; Geppetti, P; Materazzi, S; Preti, D1
Berthelot, D; BrĂ´ne, B; Geuens, I; Gijsen, HJ; Mercken, M; Zaja, M1

Reviews

1 review(s) available for dibenz(b,f)(1,4)oxazepine and allyl isothiocyanate

ArticleYear
Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.
    Journal of medicinal chemistry, 2010, Jul-22, Volume: 53, Issue:14

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Asthma; Humans; Ion Channel Gating; Neurons; Pain; Peripheral Nervous System Diseases; Pulmonary Disease, Chronic Obstructive; Transient Receptor Potential Channels

2010

Other Studies

1 other study(ies) available for dibenz(b,f)(1,4)oxazepine and allyl isothiocyanate

ArticleYear
Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.
    Journal of medicinal chemistry, 2010, Oct-14, Volume: 53, Issue:19

    Topics: Calcium; Calcium Channels; Cell Line; Dibenzazepines; Dibenzoxazepines; Fluorometry; Humans; Intracellular Space; Ligands; Membrane Potentials; Nerve Tissue Proteins; Oxazepines; Patch-Clamp Techniques; Structure-Activity Relationship; Tear Gases; Transient Receptor Potential Channels; TRPA1 Cation Channel

2010